Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Southfield-based PharmaCo Inc. — a cannabis company linked to a bribery scheme to Michigan’s then-top marijuana regulator ...

United States Steel Corp. is losing one of the members of its board of directors. Jeh C. Johnson, U.S. Homeland Security ...

The Netflix documentary ‘Don’t Die’ follows a tech millionaire’s quest to live forever. Here’s everything to know about Bryan ...

Johnson & Johnson shares are down 3% Wednesday on safety concerns that could dim sales prospects for a new heart device, ...

Dwayne Johnson now holds a greater stake in WWE, the place where his journey began. As AFROTECH™ previously reported, the ...

JNJ has an attractive 3.41% dividend yield comparable to the yield on long-term bonds. Given the lack of price movement and ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

The Man Who Wants to Live Forever introduced many viewers to the Minicircle company, and here's what the organization ...

Johnson & Johnson closed $22.62 below its 52-week high ($168.85), which the company achieved on September 4th.

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) on January 6 and set a price ...

Johnson & Johnson closed $25.19 below its 52-week high ($168.85), which the company reached on September 4th.